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Abstract This paper describes the development and valida-
tion of a new method for the simultaneous determination of
148 substances in sewage sludge. The selected compounds
belong to different classes of pharmaceuticals, including anti-
biotics, analgesic and/or anti-inflammatory drugs, antiepilep-
tics, benzodiazepines, antipsychotics, and antidepressants,
among others, and illicit drugs, including opiates, opioids,
cocaine, amphetamines, cannabinoids, and their metabolites.
As far as the authors are aware, this is the first method in the
peer-reviewed literature covering such a large number of tar-
get drugs for determination in a complex matrix like sewage
sludge. The method presented herein combines ultrasound-
assisted extraction (USE) and liquid chromatography coupled
to tandem mass spectrometry. Good analytical performance
was achieved, with limit-of-detection values below
10 ng g−1 d.w. for 91 % of the analytes and absolute recovery
in the range 50–110 % for more than 77 % of the studied
compounds. A combination of methanol and acidified water,
also containing EDTA, proved to be the optimum solvent
mixture to perform the extractions. An extra solid-phase-
extraction clean-up step was not required, substantially reduc-
ing sample-preparation time and solvent consumption. Final-
ly, the developed method was applied to the analysis of dif-
ferent sewage-sludge samples from five wastewater treatment
plants of Santorini Island (Greece). Out of the 148 target com-
pounds, 36 were detected. Several compounds, including
acetylsalicylic acid, citalopram, and ciprofloxacin among
others, had maximum concentrations above 100 ng g−1 d.w.
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Introduction
Pharmaceuticals and illicit drugs comprise a large and diverse
group of compounds designed either to be highly active and
interact with receptors in humans or to be toxic for many
pathogen organisms. After intake, these active compounds
undergo metabolic processes in organisms. Both parent com-
pounds and metabolites are excreted into raw sewage and
enter wastewater treatment systems. Because conventional
wastewater treatment processes have been revealed not to re-
move these substances completely [1–3], excretion followed
by wastewater treatment is believed to be the primary pathway
of pharmaceuticals and illicit drugs into the environment. De-
spite low concentrations, effects of these substances on the
environment and human health cannot be excluded. Several
toxic effects on aquatic organisms have been described for
many of these substances [1, 4–6], and their presence in the
ecosystem is of concern. Although the main entry of pharma-
ceuticals and illicit drugs into the environment is through
wastewater-treatment-plant (WWTP) effluents, it should be
pointed out that a smaller but important fraction of these sub-
stances remain in the sewage sludge and may be released into
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the environment through sewage application. The mecha-
nisms that control sorption onto sludge are complex and do
not only depend on the lipophilicity of the compounds. Other
factors, including solubility, vapor pressure, and the environ-
mental conditions (temperature, air disturbance, or soil
organic-matter content), are also important [7]. Therefore,
sorption processes are difficult to predict. Efforts to improve
water quality have led to a substantial increase in sewage
loads. Currently, the amount of sewage sludge generated per
person per day on average in Europe is estimated to be 90 g
d.w. [8]. Biosolids produced are mainly reused in agriculture
as soil improvement or disposed of to landfill. Despite the
clear benefits of these practices, which result in the recycling
of nutrients and organic matter, these routes constitute an ad-
ditional route of entry of organic pollutants to the environ-
ment. Consequently, detailed study of the presence of phar-
maceuticals and illicit drugs in sewage sludge is necessary to
acquire a complete description of the distribution of these
emerging pollutants in the environment and to perform a reli-
able risk assessment.
Several analytical methods for the determination of phar-
maceuticals and illicit drugs have been developed and their
presence has been widely assessed in surface water, sedi-
ments, and wastewater [4, 9, 10], revealing relevant levels of
these compounds. A small proportion of the studies dealing
with wastewater also considered the proportion attached to
suspended particulate material, where these substances were
also determined [11]. However, analytical methods for and
data on the occurrence of pharmaceuticals and illicit drugs in
sewage sludge are not abundant. Because these compounds
have a wide range of psychochemical properties and include
many polar and non-volatile substances, the most suitable
technique for their detection is liquid chromatography coupled
to tandemmass spectrometry (LC-MS/MS) because of its ver-
satility, specificity, and selectivity [12, 13]. A few methods
have been developed for the determination of pharmaceuticals
in sewage sludge [9, 14–16], in some cases including an
extensive list of up to 43 compounds [15]. The determined
concentrations vary, but they are normally below
100 ng g−1 d.w. [9, 16]. For illicit drugs only two methods
have been proposed, covering a wide variety of these com-
pounds (20 and 13, respectively, in Refs. [17, 18]). Before
this work, only a few of these substances (amphetamine,
methamphetamine, MDMA, and cocaine) had been inves-
tigated in sewage sludge, in most cases as part of a multi-
residue study that mainly included pharmaceuticals
[19–21]. The concentration ranges for these compounds
are similar to those determined for pharmaceuticals, with
higher values for cannabinoids (particularly for the parent
compounds) because of their higher lipophilicity [17, 18].
To date, an analytical method for the simultaneous analysis
of an extensive list of pharmaceuticals and illicit drugs in
sewage sludge has not been developed.
The objective of this study was to develop and validate a
robust and sensitive multi-analyte method for the simulta-
neous determination of 148 different substances, including
relevant related metabolites, in sewage sludge. The target
compounds belong to different therapeutic groups of pharma-
ceuticals (antibiotics, NSAIDs, antilipidemics, antiepileptics,
analgesics, antihypertensives, diuretics, steroids, antiulcers,
anesthetics, benzodiazepines, antipsychotics, barbiturates,
and antidepressants (tricyclic, tetracyclic, selective serotonin
re-uptake inhibitors (SSRIs), and serotonin–norepinephrine
re-uptake inhibitors (SNRIs)) and of sympathomimetics and
illicit drugs (opiates, opioids and related metabolites (includ-
ing some non-illicit compounds), cocaine and related metab-
olites, amphetamines, and hallucinogens (cannabinoids,
lysergic acid diethylamide (LSD), and derivatives)). Target
analytes were extracted by ultrasound-assisted extraction
(USE) using a mixture of water and methanol (MeOH). No
further clean-up step was necessary, substantially reducing the
overall analysis time. The extracts were further analyzed by
LC-MS/MS. The suitability of the developed method was
tested by the trace determination of the selected target phar-
maceuticals and illicit drugs in sewage sludge obtained from
fiveWWTPs of Santorini (Greece), providing new knowledge
regarding the presence of these substances in this matrix.
Experimental
Standards and reagents
CAS numbers, molecular formulas, molecular weight (g
mol−1), and other relevant properties of all target compounds
are summarized in ESM Table S1. All pharmaceutical stan-
dards were of high purity grade (>90 %) and were purchased
from Sigma–Aldrich (Athens, Greece) and LGC Promochem
(Molsheim, France) with the exception of sulfadoxine and
sulfaclozine, which were donated by the National Laboratory
of Residue Analysis of Food of Animal Origin of the Hellenic
Ministry of Rural Development and Food. Regarding psycho-
tropic and illicit drugs, all target analytes were of high purity
( 98 %). Solutions or solids were purchased from LGC
Promochem (Molsheim, France) with the exception of
topiramate and lamotrigine, which were obtained from
Glenmark (Mahwah, NJ, USA) and Sigma–Aldrich Chemie
GmbH (Steinheim, Germany), respectively. The illicit deuter-
ated compounds morphine-D3 (MOR-D3), codeine-D3
(COD-D3), cocaine-D3 (COC-D3), 2-ethylidene-1,5-dimeth-
yl-3,3-diphenylpyrrolidine-D3 (EDDP-D3), ecgonine methyl
e s t e r -D3 ( EME -D3 ) , 3 , 4 -m e t h y l e n e d i o x y -N -
m e t h y l a m p h e t a m i n e - D 5 (MDMA -D 5 ) , 3 , 4 -
me t hy l en ed i oxyamphe t am in e -D5 ) (MDA-D5) ,
tetrahydrocannabinol-D3 (THC-D3), tetrahydrocannabinolic
acid-D3 (THCA-D3), and lysergic acid diethylamide-D3
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(LSD-D3) were also obtained from LGC Promochem
(Molsheim, France). Acetonitrile (ACN), hydrochloric acid
(37 %), and MeOH LC–MS grade were purchased from
Merck (Darmstadt, Germany), and formic acid (FA) 99 %
was obtained from Sigma–Aldrich, Fluka (Buchs, Switzer-
land). Acetone (99.8 % purity) was purchased from Carlo
Erba Reagents (Val-de-Reuil, France). Ethyl acetate (EtAc)
(analytical reagent grade, 99.9 %) was obtained from Fisher
Chemicals (Loughborough, UK). Distilled water was provid-
ed by a Milli-Q purification apparatus (Millipore Direct-Q
UV, Bedford, MA, USA). Syringe filters (RC) of 4 mm diam-
eter and pore size 0.2 μm were obtained from Phenomenex
(Torrance, CA, USA). Approximately 10 mg each standard
was accurately weighed and placed in a 10 mL volumetric
flask. Penicillins, cephalosporines, macrolides, and metformin
were dissolved in Milli-Q-water, and all other analytes were
dissolved in MeOH. Stock solutions of 1.0 mg L−1 of each
compound were obtained and stored at −20 °C. From this
multi-analyte solution all working solutions were prepared
daily by appropriate dilution of the stock standard mixture
(1.0 mg L−1) and IS solutions (1.0 mg L−1, containing all the
aforementioned deuterated standards) in MeOH. Calibration
standards were prepared by serial dilution of the mixed work-
ing solution usingMilli-Qwater with 0.05% (v/v) formic acid,
resulting in individual concentrations ranging from 0.2 to
100 μg L−1.
Sample collection and preparation
Treated sewage-sludge samples were collected in July 2013
from fiveWWTPs of Santorini, an island located in the south-
ern Aegean Sea (Greece). Sampling locations are described in
detail in a study by Borova et al. [22]. The plants of Kamari,
Fira, and Ia are located in very touristy spots, where in sum-
mer periods (when this monitoring was performed) the popu-
lation increases substantially. Karterados and Emporio
WWTPs serve a more stable population which does not expe-
rience the effects of tourism in such a pronounced way.
The studied WWTPs serve population equivalents in the
range 3,000 to 16,000 people. The wastewater treatment in all
the investigated WWTPs consists of a preliminary clarifica-
tion step followed by a biological treatment consisting of the
conventional activated sludge process (CAS). The generated
sludge is treated in two stages: aeration and dewatering. An-
aerobic digestion is not performed. The average sludge pro-
duction in the studied WWTPs ranged from 390 to
3500 kg day−1.
Different grab samples were randomly collected and com-
bined at each WWTP, providing a final sample weighing ap-
proximately 500 g. Samples were collected in antimicrobial
plastic bags after sewage-sludge dewatering, properly sealed,
and shipped in refrigerated coolers to the laboratory. They
were then freeze-dried and stored in the dark at −20 °C until
analysis.
Extraction
In the optimized method, 0.1 g freeze-dried sewage sludge
was placed in a plastic centrifuge tube (15 mL), spiked with
the corresponding surrogates, and kept in contact overnight.
The sample was then extracted with 2 mL MeOH–Milli-Q
water (pH 2.5, FA 0.5 % and 0.1 % EDTA), 50:50 (v/v), by
vortex (1 min), followed by ultrasonic extraction for 15 min at
50 °C. After the extraction the extract was centrifuged for
10 min (4000 rpm) and the supernatant was collected in a
glass test tube. This procedure was repeated two more times.
In total 6 mL supernatant was collected. Then the total extract
was evaporated to dryness under a gentle steam of N2 at 40 °C.
Reconstitution of the analytes was performed with 0.5 mL
MeOH–water (0.05 % FA), 25:75 (v/v). Finally, the extract
was filtered through a 0.2 μm RC syringe filter and then the
samples were transferred to a glass vial for HPLC–MS/MS
analysis.
LC–MS/MS analysis
The LC-MS/MS method for the analysis of the 148 target
analytes was developed by merging two existing methods
for pharmaceuticals and drugs of abuse [22, 23]. Instrumental
analysis was performed with a Thermo UHPLC Accela sys-
tem connected to a TSQ Quantum Access triple-quadrupole
mass spectrometer from Thermo Electron Corporation (San
Jose, CA, USA) equipped with an electrospray-ionization
(ESI) source (Thermo IonMAX) operated in both positive
and negative mode. Chromatographic separation was
achieved on an Atlantis T3 C18 (100×2.1 mm, 3 μm) column
from Waters Corporation (Milford, MS, USA). The mobile
phase for the positive-detection mode consisted of water
(0.01 % FA (v/v)) and MeOH, and that for the negative-
detection mode consisted of water (1 mmol L−1 ammonium
formate), MeOH, and ACN (at a constant proportion of 5 %).
The elution gradient for ESI(+) mode started with 5 %
MeOH for 3 min, then increasing to 100 % in 17 min, held
at 100 % for 9 min, and finally returning to the initial condi-
tions in the next minute. The necessary time for the re-
equilibration of the analytical column was 15 min. The total
run time for each injection was 45 min. The ESI(+) operation-
al settings were: capillary voltage, 3500 V; capillary tempera-
ture, 270 °C; sheath gas, 30 psi; and auxiliary (drying) gas,
10 a.u. The elution gradient for ESI(−) started with 25 %
MeOH and 5 % ACN (which was kept constant throughout
the elution). MeOH was then increased to 95 % in 10 min and
kept constant for 13 min, before a return to the initial condi-
tions over the next minute. The time for the re-equilibration
was 13 min. The total run time for each injection was 37 min.
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The ESI(−) operational settings were: capillary voltage,
2500 V; capillary temperature, 270 °C; sheath gas, 20 psi;
and auxiliary (drying) gas 10 a.u. In both cases the injection
volume was set to 10 μL and the mobile-phase flow to
100 μL min−1.
The optimized ionization mode, fragmentation voltages,
and collision energies for each compound have been described
in detail by Borova et al. and Dasenaki et al. [22, 23]. Data
acquisition and evaluation were performed with Excalibur
software (Thermo Electron Corporation). Identification and
quantification were performed in selected-reaction-
monitoring (SRM) mode, recording the transitions between
the precursor ion and the two most abundant product ions
for each target analyte, thus achieving four identification
points per compound (2002/657/EC).
Validation
The developed method was evaluated under the optimized
conditions in terms of linearity range, sensitivity, accuracy,
reproducibility, and matrix effects.
A Certified Reference Material (CRM 145R, sewage
sludge) from the European Commission was used for method
development and validation. Spiked samples at a concentra-
tion of 40 ng g−1 d.w. were extracted sixfold. The CRM was
certified for metals and was never analyzed for emerging con-
taminants (Description of the CRM properties: http://www.
irmm.jrc.be/html/reference_materials_catalogue/catalogue/
attachements/BCR-145r_cert.pdf). However, the presence of
the target compounds was evaluated and positive results were
obtained for 10 of the 148 analytes. None of the analyzed
illicit drugs were detected in the CRM. The detected
concentrations in the CRM145R sample are summarized in
ESM Table S2.
Blank tests were performed to rule out possible contamina-
tion from the sampling, storage, or instrumentation. To com-
ply with internal quality-control procedures, two control
spiked samples, two solvent injections, and two procedural
blanks were inserted into each analytical batch of twelve sam-
ples. The individual values obtained for control samples were
plotted on a process-behavior chart throughout the study to
establish whether the analysis was in a state of statistical
control.
Results and discussion
Chromatography optimization
While merging the two methods on which the presented meth-
od is based [22, 23], different variables were investigated and
optimized to achieve the best compromise conditions for all
compounds.
An Atlantis T3 C18 column (100×2.1 mm, 3 μm), pre-
viously used for the analysis of 89 pharmaceuticals [23],
was selected for the analysis of the 148 compounds because
it had an overall good performance for both pharmaceutical
and illicit-drug compounds. Both sensitivity and peak
shape worsened significantly for morphine and ecgonine
methyl ester (EME) when using the Atlantis T3 C18 col-
umn compared with the pentafluorophenyl (PFP) column
used in Ref. [22]. For some other illicit drugs the sensitivity
decreased slightly, but these changes were not significant.
However, the PFP column presented many more problems
for several pharmaceuticals, particularly the most lipophilic
ones.
MeOH had a better overall performance than ACN for
most of the studied compounds (e.g. penicillins, beta-
blockers, steroids, opioids and opiates, cocaine compounds,
antidepressants, anesthetics, benzodiazepines, amphetamine
compounds, and antiepileptics). FAwas added in the aqueous
phase because its addition at low concentrations resulted in a
significant improvement in peak shape and sensitivity when
working in ESI(+). The mobile phase of choice for the ESI(+)
detection mode consisted of water (0.01 % FA (v/v)) and
MeOH as organic phase. Although the increase of FA to
0.05 % (v/v) positively affected the sensitivity for some drugs
(e.g. antipsychotics), it usually had a negative effect for phar-
maceuticals. Acidic additives in the organic phase were also
tested, revealing that for most pharmaceuticals this caused a
decrease in sensitivity. However, it was observed that the ad-
dition of a small amount of FA into the vial before injection
into the LC-MS/MS system led to a very significant improve-
ment of the sensitivity for many compounds. Figure S3a
(Electronic Supplementary Material (ESM)) shows the effect
of this condition for the different compound families studied.
For some compounds, including some benzodiazepines, anti-
biotics, and NSAIDs, the sensitivity decreased on adding FA.
For other substances, including many amphoteric compounds
(e.g. sulfonamides), changes in acidic or basic conditions had
little effect. However, most substances experienced a clear
improvement. For some compounds (e.g. morphine and
olanzapine) a significant increase in sensitivity was obtained
on increasing FA concentration from 0.01 to 0.1 % (v/v).
However, the behavior of most of the compounds changed
little in that FA concentration range. A final FA concentration
of 0.05 % (v/v) was chosen to achieve the best compromise
conditions.
In ESI(−) mode the conditions described by Dasenaki et al.
[23] were used, because they resulted in an overall good per-
formance of the analytical method for all the compounds.
Figure S3b shows the SRM chromatograms for all the tar-
get analytes under the optimized LC-MS/MS conditions. The
SRM transitions used for quantification, the chromatography
retention times, and the ESImode used for each compound are
also indicated in this figure.
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USE extraction
USE was the technique of choice because it provided short
extraction times, low solvent consumption, and good recover-
ies. Another reason was the fact that it can process a large
number of samples simultaneously, thereby reducing the total
time of the sample preparation before the instrumental
analysis.
In the optimization of a method using USE, extraction sol-
vent mixture and extraction temperature are the most impor-
tant conditions. The optimization of these crucial factors was
performed by analyzing treated sludge (0.1 g) spiked in trip-
licate to 100 ng g−1 d.w. and blank samples, and calculating
recoveries on the basis of peak area for each tested condition.
Because of the wide range of physicochemical properties of
the compounds selected for this study, a solvent with some
organic content in water (possibly a different combination for
each separate analyte) was likely to provide the best recover-
ies. Different solvent mixtures were tested to optimize the
procedure, including water, water–MeOH 1:1 (v/v), MeOH,
acetone, water–MeOH–acetone 1:1:1 (v/v), EtAc, water–
MeOH–EtAc 1:1:1 (v/v), and ACN. As some studies suggest,
acidic conditions can lead to higher extraction efficiencies for
the compounds of interest [11, 24, 25]. Better recoveries for
most compounds were obtained when using acidified water
(FA 0.5 %, (v/v)) instead of water, as can be observed from
Fig. 1a (combinations S1 and S3). Therefore, the rest of the
experiments were performed using acidified water. EDTAwas
added to all the solvent mixtures during optimization because
it was proved in previous experiments to improve the extrac-
tion recoveries. The temperature for these experiments was set
to 40 °C. The recoveries obtained when the different mixtures
were tested are shown in Fig. 1a and ESM Table S4. The best
results were obtained by using three×2 mL of a mixture of
acidified water with formic acid 0.5 % (pH=2.5) and 0.1 %
EDTA–MeOH (1:1, (v/v)). Under these conditions more than
70% of the analytes were extracted, with an absolute recovery
in the range 50–120 %. These conditions also resulted in the
lowest number of compounds with recoveries below 20 %
(8 % of the analytes). In almost every case, the use of acetone,
EtAc, or ACN did not improve the results.
Temperature is another important variable. Low tempera-
ture can lead to lower extraction efficiency, but too-high tem-
peratures can also decrease recoveries. This may be the result
of thermal degradation of analytes or loss of selectivity in the
method, leading to the more efficient release of interfering
matrix components [11]. The objective was to find the tem-
perature which enables the maximum recovery without giving
rise to a significant increase of matrix effect. Figure 1b shows
the results obtained at 40 °C, 50 °C, and 60 °C. The increase in
temperature to 50 °C led to a slight increase in the recovery of
some compounds, whereas the rest remained stable. On in-
creasing the temperature to 60 °C there was a significant
decrease in the extraction efficiency for some analytes, and
an increase in recoveries above 120 %. These results are prob-
ably a consequence of the increased interfering matrix com-
ponents that were co-extracted under these conditions. How-
ever, some analytes had higher extraction efficiencies at that
temperature (e.g. cefalosporines, salicylic acid, and several
benzodiazepines). Finally, 50 °C was selected as the optimum
temperature for the extractions, providing the best compro-
mise conditions for all compounds.
The amount of sample used in the extraction was also stud-
ied. Experiments with 0.2, 0.5, and 1 g were conducted but did
not lead to lower method limits of detection (MLODs) than
the experiments performed with 0.1 g, whereas recoveries
decreased and matrix effect increased. As in the case of in-
creased temperature, this may be caused by the co-extraction
of interfering matrix components that negatively affect
sensitivity.
Method validation
The identification and confirmation criteria for the analysis of
the target substances were based on the Commission Decision
2002/657/EC. To confirm the presence of the compounds, the
retention time of the compounds (2.5 % of tolerance) and
relationship between the two transitions (difference of less
than 20 %) were compared. For each compound, the SRM
transition with the highest intensity was used for quantifica-
tion, and the other transition was used for confirmation. Quan-
tification was based on standard additions, and isotopically
labeled compounds were used only for the quantification of
those compounds in which isotopic analogue compounds
were available.
Seven-point calibration curves (0.1–100 ng mL−1, equiva-
lent concentration in the sludge sample 0.5–500 ng g−1 d.w.)
were generated using linear-regression analysis. The linearity
was qualified by the linear correlation coefficient, r2. The
calibration curves obtained for the SRM transitions were lin-
ear, with r2 0.99 in all cases. Instrumental limits of detection
and quantification for the target compounds and instrumental
precision are described in Refs. [22, 23].
The main variables for the method performance are sum-
marized in Table 1. MLODs and method limits of quantifica-
tion (MLOQ) were calculated by analyzing the spiked sam-
ples seven times. For compounds at the relevant concentration
in the blank (e.g. caffeine, doxycycline), replicate analyses of
the same sample were performed. MLODs were calculated as
follows: the standard deviation of the lowest spiked concen-
tration (40 ng g−1 d.w.) or the standard deviation of the repli-
cate analyses (for abundant compounds) was multiplied by
three and then divided by the slope of the calibration curve
of spiked samples. MLOD values were below 10 ng g−1 d.w.
for more than 91 % of the target compounds (Fig. 2a).
MLODs were always below 20 ng g−1 d.w. The reported
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MLODs and MLOQs enable reliable detection and quantifi-
cation of the target compounds at their typical levels in
sewage-sludge samples. Recoveries of the overall method
were calculated by analyzing sewage-sludge samples
(CRM145R) (n=6) fortified at 40 ng g−1 d.w. As indicated
previously, the presence of the target analytes was investigated
in the CRM material (results summarized in ESM Table S2).
Although some compounds were detected, the concentrations
in most cases were low and enabled an accurate estimation of
the recoveries at the working concentration level. The com-
pounds detected at high concentration (caffeine, ofloxacin,
clozapine, doxycycline, and risperidone) were spiked at
100 ng g−1 d.w. Most of the studied compounds (77 %) had
recoveries in the range 50–110 % (Fig. 2b), and more than
41 % in the range 80–110 %. Only 10 out of the 148 studied
compounds had recoveries below 30 %. These substances
were among the most lipophilic ones, almost all of them with
log KOW (KOW=octanol–water distribution coefficient) values
above four (chlorpromazine, clomipramine, and gemfibrozil,
among others), revealing lower recovery efficiency for this
type of compound. Considering that this study intended to
analyze a large number of analytes with a wide range of psy-
chochemical properties, the results were quite successful.
Moreover, the low recoveries obtained in some cases were
not regarded as an obstacle to their reliable determination,
because their sensitivity and reproducibility were satisfactory.
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Fig. 1 Optimization of the (a) solvent mixture and (b) temperature. The
color and pattern code refers to the different intervals of recovery
efficiency. The temperature during ultrasound-assisted extraction was
40 °C. S1: 3×2 mL mixture of water with 0.1 % EDTA–methanol
(1:1). S2: 2 mL acidified water with formic acid 0.5 % (pH=2.5) and
0.1 % EDTA, 2 mLmixture of acidified water with formic acid–methanol
(1:1), 2 mLmethanol. S3: 3×2 mLmixture of acidified water with formic
acid 0.5 % (pH=2.5) and 0.1 % EDTA–methanol (1:1). Chosen
conditions. S4: 2 mL acidified water with formic acid 0.5 % (pH=2.5)
and 0.1 % EDTA, 2 mLmethanol, 2 mL acetone. S5: 3×2 mL mixture of
acidified water with formic acid 0.5 % (pH=2.5) and 0.1 % EDTA–
methanol–acetone (1:1:1). S6: 2 mL acidified water with formic acid
0.5 % (pH=2.5) and 0.1 % EDTA, 2 mL methanol, 2 mL ethyl acetate.
S7: 3×2 mL mixture of acidified water with formic acid 0.5 % (pH=2.5)
and 0.1 % EDTA–methanol–ethyl acetate (1:1:1). S8: 2 mL acidified
water with formic acid 0.5% (pH=2.5) and 0.1%EDTA, 2mLmethanol,
2 mL acetonitrile. S9: 3×2 mL mixture of acidified water with formic
acid 0.5 % (pH=2.5) and 0.1 % EDTA–methanol–acetonitrile (1:1:1)
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Table 1 Performance of the method
MLOD
(ng g−1
d.w.)
MLOQ
(ng g−1
d.w.)
REC (%)
(40 ng g−1,
n=6)
RSD
(%)
(n=6)
ME
(%)
Pharmaceuticals
7-Aminoflunitrazepam 7.5 24.8 35 10 −60
8-OH mirtazapine 1.4 4.7 87 12 −31
9-OH Risperidone 4.3 14.3 32 18 −31
Acetylsalicylic acid 13.8 46.0 126 20 −84
Alprazolam 3.2 10.6 73 16 −18
Amitriptyline 5.1 16.8 30 17 −51
Amoxicillin 16.4 54.7 62 20 −64
Atenolol 5.1 16.9 94 11 −18
Atorvastatin 2.7 9.1 31 16 −23
Azithromycin 6.5 21.6 92 19 63
Betamethasone 4.4 14.7 77 14 −56
Bromazepam 1.0 3.5 68 13 11
Caffeine 3.3 10.9 104 6 −80
Carbamazepine 4.4 14.7 76 12 −19
Cefaclor 0.8 2.7 90 19 −64
Cefadroxil 3.3 10.9 83 9 −61
Cefalexin 3.2 10.7 100 19 −29
Cefazolin 16.3 52.8 88 16 −35
Chloramphenicol 9.5 31.7 84 15 −40
Chlordiazepoxide 3.1 10.3 66 16 −21
Chlorpromazine 3.2 10.7 16 16 −64
Chlortetracycline 13.0 43.2 81 13 −46
Cimetidine 3.8 12.5 78 9 −3
Ciprofloxacin 3.2 10.7 107 9 −76
Citalopram 3.6 11.9 73 15 −35
Clarithromycin 3.3 11.0 73 8 −25
Clobazam 5.5 18.3 79 10 −49
Clofibric acid 8.3 27.9 87 11 −15
Clomipramine 5.0 16.5 21 12 −58
Clozapine 4.0 13.3 38 20 −38
Cortisol 5.5 18.4 94 12 −52
Cortisone 4.9 16.4 85 12 −60
Diazepam 5.5 18.4 52 20 −16
Diclofenac 10.3 34.1 27 14 −18
Dicloxacillin 19.9 66.3 79 17 90
Difloxacin 4.1 13.5 43 13 −13
Doxepin 2.9 9.6 42 10 15
Doxycycline 9.5 31.7 105 10 −92
Enrofloxacin 6.3 21.9 50 15 14
Ephedrine 0.9 3.1 92 9 −64
Fentanyl 1.8 6.0 58 20 −26
Florfenicol 5.1 17.0 100 5 −32
Flunitrazepam 1.5 5.1 64 6 −24
Fluoxetine 5.3 17.5 19 7 −59
Furosemide 6.3 21.9 90 11 −11
Gemfibrozil 5.1 17.0 17 12 −56
Table 1 (continued)
MLOD
(ng g−1
d.w.)
MLOQ
(ng g−1
d.w.)
REC (%)
(40 ng g−1,
n=6)
RSD
(%)
(n=6)
ME
(%)
Hydrochlorothiazide 5.4 17.8 80 9 −59
Ibuprofen 11.7 38.6 32 17 −43
Imipramine 1.5 5.1 27 17 −45
Indapamide 5.0 16.7 72 17 −50
Ketamine 2.7 9.1 97 9 −22
Ketoprofen 4.1 13.5 78 16 −56
Lamotrigine 4.6 15.2 72 9 −39
Levetiracetam 7.0 23.1 96 7 −43
Lidocaine 2.3 7.6 97 5 −26
Lincomycin 3.4 11.4 91 15 −13
Lorazepam 3.4 11.2 63 8 −31
Marbofloxacin 6.7 22.1 64 8 28
Mefenamic acid 7.4 24.6 28 9 −56
Meloxicam 5.4 17.9 48 9 −41
Metformin 10.2 34.0 88 12 −85
Methylprednisolone 3.5 11.6 86 15 −53
Metronidazole 3.2 10.8 95 13 −37
Metoprolol 5.1 16.8 93 9 −30
Midazolam 2.9 9.7 62 13 −29
Mirtazapine 0.9 3.1 77 12 −16
Naproxen 4.0 12.2 45 18 −36
Niflumic acid 4.7 15.5 42 14 −11
Nitrazepam 0.9 3.0 55 17 −15
Norclozapine 3.0 9.9 30 15 31
Nordiazepam 4.0 12.2 42 12 −19
Norephedrine 1.4 4.7 96 11 −23
Norfentanyl 1.5 4.9 94 7 −14
Norfloxacin 5.1 16.8 87 13 17
Norketamine 0.9 3.0 96 14 −24
Norsertraline 5.1 16.8 47 11 −75
Nortriptyline 2.3 7.7 30 20 −14
Ofloxacin 0.9 3.1 90 9 −8
Olanzapine 0.7 2.3 47 9 −13
Omeprazole 7.9 26.1 93 12 −45
Oxazepam 3.2 10.6 65 16 −15
Oxolinic acid 5.8 19.1 76 3 −27
Oxytetracycline 2.2 7.3 91 9 −44
Paracetamol 10.0 30.3 97 15 −49
Paroxetine 3.1 10.4 22 16 −50
Pentobarbital 1.1 3.80 119 15 −87
Phenobarbital 1.8 6.11 87 15 −31
Phenytoin 5.8 19.1 76 20 −24
Primidone 4.4 14.5 95 17 −59
Progesterone 3.3 11.1 71 20 −51
Propranolol 3.1 10.4 53 12 −26
Ranitidine 1.2 4.0 42 16 −61
Risperidone 5.4 17.9 26 20 −12
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To ensure a correct quantification, method precision was de-
termined as relative standard deviation (%RSD) from the re-
covery experiments (n=6, 40 ng g−1 d.w.), processed by the
method described (method repeatability). The precision limit
of <20 % RSD was met for all analytes, indicating the good
precision of the method.
Matrix effect is an important variable in the performance of
LC-MS/MS analysis in complex matrices, including sewage
sludge [26]. This variable was evaluated and the results,
expressed as percentage of suppression or enhancement, are
summarized in Table 1. In most cases, signal suppression was
in the range −92 to −3. Only for 12 out of the 148 target
compounds was signal enhancement observed, in the range
11–90 %.
Table 1 (continued)
MLOD
(ng g−1
d.w.)
MLOQ
(ng g−1
d.w.)
REC (%)
(40 ng g−1,
n=6)
RSD
(%)
(n=6)
ME
(%)
Ronidazole 5.7 19.0 104 10 −62
Salicylic acid 3.0 9.8 99 7 −61
Sarafloxacin 1.0 3.3 43 10 −24
Sertraline 2.7 8.9 36 14 −55
Simvastatin 2.3 7.5 20 20 −56
Sulfachloropyridazine 4.4 14.5 56 20 −24
Sulfaclozine 10.7 35.7 56 12 −72
Sulfadiazine 5.7 19.0 70 13 −46
Sulfadimethoxine 5.0 16.8 52 10 −31
Sulfadimidine 3.8 12.6 59 14 −39
Sulfadoxine 4.7 15.8 61 11 −37
Sulfaguanidine 16.4 54.6 56 16 −19
Sulfamerazine 2.8 9.3 70 16 −50
Sulfamethizole 3.0 9.8 57 16 −59
Sulfamethoxazole 4.0 12.2 63 9 −56
Sulfamethoxypyridazine 7.8 25.9 55 11 −38
Sulfamonomethoxine 4.0 13.3 57 13 −43
Sulfamoxole 5.0 16.7 60 16 −60
Sulfapyridine 4.0 12.2 52 15 −37
Sulfathiazole 3.6 11.9 66 17 −51
Sulfisoxazole 7.8 25.9 61 15 −42
Temazepam 1.5 4.9 61 12 −16
Tetracycline 10.1 33.6 78 16 −58
Theophylline 3.6 11.9 98 11 −69
Thiamphenicol 6.1 20.3 107 16 −80
Thiopental 1.4 4.6 40 20 −87
Tiamulin 3.3 11.1 51 9 −34
Topiramate 2.0 6.6 95 14 −84
Tramadol 2.8 9.2 88 8 −20
Triamterene 3.0 10.1 68 9 −31
Trimethoprim 1.0 3.3 83 9 −18
Tylosin 5.7 19.0 78 8 −22
Valproic acid 12.9 43.0 107 6 38
Valsartan 7.2 23.8 72 14 −19
Venlafaxine 2.4 7.9 89 11 −21
Zopiclone 4.6 15.4 88 11 −28
Illicit drugsa
6-monoacetylmorphine 4.6 15.4 100 10 −22
Amphetamine 1.5 5.0 97 15 −27
Benzoylecgonine 2.3 7.6 95 7 −27
Buprenorphine 0.6 2.0 50 16 −13
Cocaine 4.5 15.1 92 12 −12
Codeine 3.3 10.9 99 17 −43
EME 6.5 21.5 95 8 −75
EDDP 2.9 9.6 68 13 −19
Heroin 0.6 1.9 91 9 −21
LSD 4.8 16.1 60 10 −18
Table 1 (continued)
MLOD
(ng g−1
d.w.)
MLOQ
(ng g−1
d.w.)
REC (%)
(40 ng g−1,
n=6)
RSD
(%)
(n=6)
ME
(%)
LSD-OH 6.1 20.1 81 14 49
MDA 3.5 11.6 97 15 −34
MDEA 4.3 14.3 94 13 −37
MDMA 2.5 8.4 90 6 24
Methadone 4.7 15.8 46 14 −27
Methamphetamine 0.9 2.9 87 8 27
Morphine 2.5 8.2 101 13 −31
Oxycodone 3.9 12.9 101 9 −28
THCA 14.3 47.7 31 20 −78
MLOD: method limit of detection; MLOQ: method limit of quantifica-
tion; REC: recovery; ME: matrix effect
a For the sake of convenience all the opioids and opiates have been
grouped as illicit drugs
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Application to real samples
The developed multi-residue method was used to evaluate
the presence of the target compounds in different sewage-
sludge samples collected from five different WWTPs in
Santorini (Greece), as described in BSample collection
and preparation^. Table 2 shows the concentration values
for every compound in each sample, and summarizes the
frequencies of detection, the mean and median concentra-
tions, and the ranges of concentration of the evaluated sub-
stances. Values<LOQ were computed in the frequency be-
cause they were regarded as detected. In these cases, a
value of LOQ/2 was assigned for calculating the mean
and the median. Undetected compounds were not included
in the table. Out of the 148 target compounds, 36 were
determined at least in one sample, with mean and median
concentrations up to 208 ng g−1 d.w. and 219 ng g−1 d.w.,
respectively.
Higher frequencies of detection (FD) and mean con-
centrations (MC) were obtained for compounds with rel-
atively high values of log KOW. Among these com-
pound s we r e a z i t h r omyc i n (FD 100 %, MC
155.5 ng g−1 d.w.), amitriptyline (FD 100 %, MC
116.4 ng g−1 d.w.), diclofenac (FD 100 %, MC
40.9 ng g−1 d.w.), niflumic acid (FD 100 %, MC
43.5 ng g−1 d.w.), and sertraline (FD 100 %, MC
57.9 ng g−1 d.w.). Although the levels of some com-
pounds in industrial wastewater (IWW) are not very
high, these compounds are easily adsorbed onto the
sludge and they can be determined at relevant levels.
Furthermore, the results revealed high FD and MC for
compounds that are not particularly lipophilic, but are
present at high concentrations in the corresponding
IWWs. As mentioned previously, sorption onto sludge
does not only depend on the lipophilicity of the com-
pounds, although it is an important factor. This was re-
vealed by Yamamoto et al. [7], who found a weak rela-
tionship between the carbon-specific equilibrium sorp-
tion constant (KOC) and the octanol–water distribution
coefficient (KOW) when studying a large number of phar-
maceuticals. Other factors, including pH, temperature,
and ionic strength, also have an important effect and
make it difficult to predict sorption processes. Among
the compounds were acetylsalicylic acid (FD 100 %,
MC 208.3 ng g−1 d.w.), metformin (FD 100 %, MC
64.5 ng g−1 d.w.), norfloxacin (FD 100 %, MC
52.9 ng g−1 d.w.), carbamazepine (FD 100 %, MC
41.8 ng g−1 d.w.), valproic acid (FD 100 %, MC
92.8 ng g−1 d.w.), tetracycline (FD 100 %, MC
100.0 ng g−1 d.w.), ciprofloxacin (FD 100 %, MC
78.5 ng g−1 d.w.), and citalopram (FD 100 %, MC
134.6 ng g−1 d.w.). All these compounds were deter-
mined at high concentrations in IWWs in other studies
performed at the same sampling points [22] or at other
places in Greece [23].
Also noteworthy is the high levels obtained for the me-
tabolite 3,4-methylenedioxyamphetamine (MDA) (FD
60 %, MC 26.8 ng g−1 d.w.), indicating substantial con-
sumption of 3,4-methylenedioxy-N-methylamphetamine
(MDMA), a popular recreational drug. MDA was deter-
mined at higher levels in the sludge of the WWTPs of
Kamari, Fira, and Ia, which are located in very touristy
spots compared with the Karterados and Emporio WWTPs,
which serve a more stable population and for which the
concentration of this compound was significantly lower.
However, THCA, a major metabolite of THC, was not de-
tected in any sample. This compound is highly lipophilic
and it is likely to be found in sludge [17], because consump-
tion of THC is normally quite high. The reason for its non-
detection could be the high MLOD obtained for THCA.
Nevertheless, for most of the compounds no significant
differences were observed among the levels for the different
WWTPs evaluated, indicating a substantial use of the de-
tected substances throughout the whole island. It is also
important to remark that the monitoring study was per-
formed with grab samples, and solid long-term conclusions
cannot be extracted.
Conclusions
Amulti-residue method based on USE and further analysis by
LC-MS/MS was developed and optimized for the determina-
tion in sewage sludge of pharmaceuticals and illicit drugs with
a wide range of psychochemical properties. This method is the
first one enabling the determination of an extensive list of both
pharmaceuticals and illicit drugs in sewage sludge. Good an-
alytical performance was achieved, with MLODs below
10 ng g−1 d.w. for 91 % of the analytes, enabling a reliable
quantification of the target compounds in the complex select-
ed matrix. The developed USE extractionmethod, and the fact
that an extra clean-up step was not required, mean that the
sample preparation is fast, efficient and non-tedious. Amixture
of water and MeOH proved to be the optimum solvent to
perform the USE extraction. The use of acidified water and
EDTA significantly improved the extraction efficiency for sev-
eral compounds. The optimization of the amount of sample
and the extraction temperature also proved to be important.
The addition of a small amount of FA into the vial before
injection into the LC-MS/MS system led to a very significant
improvement of the sensitivity for many compounds in ESI(+).
In the analysis of five different sewage-sludge samples
from different WWTPs of Santorini 36 compounds were
determined, some at concentrations above 100 ng g−1 d.w.
The frequencies of detection and the mean concentrations
were particularly high for the most lipophilic compounds
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(e.g. amitriptyline and sertraline) and also for those previ-
ously detected in these spots at high concentrations in IWW
(e.g. acetylsalicylic acid and metformin). It should be point-
ed out that the treated sludge generated in the evaluated
WWTPs is used in some cases as fertilizer in agriculture,
and these practices may contribute to transferring these
compounds to surface and groundwater. The target sub-
stances may be re-introduced into the water cycle and even-
tually into the food chain. Therefore, a greater knowledge
regarding the presence and behavior of these compounds in
sewage sludge is necessary to ensure safer management of
the generated biosolids.
Table 2 Concentrations of the detected compounds in sewage sludge from five WWTPs of Santorini Island. Mean, median, concentration range, and
frequency of detection
Kamari Fira Karterados Emporio Ia Mean
(ng g−1 d.w.)
Median
(ng g−1 d.w.)
Range
(ng g−1 d.w.)
Frequency of
detection (%)
Pharmaceuticals
8-OH mirtazapine n.d. 7.1 n.d. <LOQ <LOQ 3.0 2.4 <LOQ–7.1 60
Acetylsalicylic acid 209 226 143 219 244 208 219 143–244 100
Alprazolam <LOQ <LOQ n.d n.d n.d – – – 40
Amitriptyline 227 102 32.3 70.2 151 116 102 32.3–227 100
Azithromycin 149 267 228 72.8 60.8 156 149 60.8–267 100
Caffeine <LOQ <LOQ 13.4 n.d. 14.5 8.1 5.5 <LOQ–14.5 80
Carbamazepine 30.8 29.1 18.0 113 18.4 41.8 29.1 18.0–113 100
Cimetidine n.d n.d 51.0 <LOQ 17.6 15.7 6.3 <LOQ–51.0 60
Ciprofloxacin 34.1 100 72.4 55.7 115 78.5 72.4 34.1–115 100
Citalopram 168 113 110 130 153 135 130 110–168 100
Clarithromycin 16.3 41.4 <LOQ <LOQ 21.1 18.0 16.3 <LOQ–41.1 100
Clomipramine 24.6 n.d. 67.1 <LOQ <LOQ 22.1 8.3 <LOQ–67.1 80
Clozapine 21.0 n.d. 49.9 n.d n.d 15.4 2.0 21.0–49.9 40
Diclofenac 39.1 42.1 40.9 <LOQ 65.3 40.9 40.9 <LOQ–65.3 100
Doxycycline 64.0 154 179 81.3 77.1 111 81.3 64.0–179 100
Ephedrine 24.2 75.2 17.0 <LOQ 47.5 33.1 24.2 <LOQ–75.2 100
Fluoxetine 35.3 n.d. <LOQ 36.8 n.d. 17.3 8.8 <LOQ–36.8 60
Metformin 75.2 65.6 62.0 41.4 78.2 64.5 65.6 41.4–78.2 100
Metoprolol 16.2 <LOQ n.d n.d. <LOQ 6.3 5.8 <LOQ–16.2 60
Mirtazapine 26.8 16.7 25.7 32.8 12.7 22.9 25.7 12.7–32.8 100
Niflumic acid 36.4 26.5 60.2 67.4 27.2 43.5 36.4 26.5–67.4 100
Norfloxacin 36.7 63.9 76.6 50.8 36.6 52.9 50.8 36.6–76.6 100
Nortriptyline 24.0 34.0 18.0 <LOQ 42.1 25.3 24.0 <LOQ–42.1 100
Ofloxacin 23.0 35.9 21.0 15.0 42.0 27.4 23.0 15.0–42.0 100
Oxytetracycline 159 30.9 119 8.9 30.8 69.7 30.9 8.9–159 100
Propranolol 21.7 n.d. n.d. n.d. 24.1 10.1 1.6 21.7–24.1 40
Ranitidine 32.7 12.5 17.8 10.1 n.d. 14.7 12.5 10.1–32.7 80
Salicylic acid 17.3 33.1 14.2 13.8 12.1 18.1 14.2 12.1–33.1 100
Sertraline 42.8 65.1 52.9 20.1 108 57.9 52.9 20.1–108 100
Sulfapyridine 34.5 21.5 23.3 31.1 12.1 24.5 23.3 12.1–34.5 100
Tetracycline 125 191 71.6 <LOQ 102 100 102 <LOQ–191 100
Tramadol 35.8 24.5 26.7 30.5 37.3 31.0 30.5 24.5–37.3 100
Valproic acid 89.3 55.8 129 93.7 96.0 92.8 93.7 55.8–129 100
Venlafaxine 29.6 n.d. 35.7 <LOQ n.d. 14.3 4.0 <LOQ–35.7 60
Illicit drugs
Codeinea n.d n.d 21.0 <LOQ n.d. 6.3 1.7 <LOQ–21.0 40
MDA 24.7 77.3 <LOQ <LOQ 20.5 26.8 20.5 <LOQ–77.3 100
n.d., not detected; <LOQ, below limit of quantification
a Opiate compound but not illicit
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